BrainStorm Cell Therapeutics Inc. (BCLI) - NASDAQ
  • Wall Street Titan | Send Message 3 Jun

    Brainstorm Cell Therapeutics: Caution Ahead Of ALS Phase II Data $BCLI http://seekingalpha.com/a/2daq9
    Reply
      • Life Sciences Report | Send Message 2 Mar

        Embrace Low-Cap Biotech For High Gains: Eden Rahim Of Next Edge Capital $ACAD, $BCLI, $CPHR http://seekingalpha.com/p/2w2eg
        Reply
          • David Bautz | Send Message 14 Jan

            Misunderstanding Surrounding BrainStorm Data Publication Presents Buying Opportunity $BCLI http://seekingalpha.com/a/29o92
            Reply
              • Life Sciences Report | Send Message 13 Jan

                " $BCLI and Hadassah Medical agreed to a Phase 2 AML trial collaboration"- Jason Kolbert. Read more: http://ow.ly/X1U65
                Reply
                  • wilkinson99 | Send Message 8 Jan

                    Premarket Top % Gainers: $SIEN 35%, $GLO 23%, $ATHX 20%, $XBIT 16%, $FCEL 14%, $SUNEQ 12% $TLGT $BCLI $SID $CPST $JKS $NETE $LGIH $EPE $NVCR
                    Reply
                      • Life Sciences Report | Send Message 23 Dec 2015

                        " $BCLI may be positioned for a Phase 3 trial of NurOwn in 2017"- Jason Kolbert. Read more: http://ow.ly/Whl8N
                        Reply
                          • Life Sciences Report | Send Message 2 Dec 2015

                            "With $BCLI, we didn't have to struggle with safety"- Jason Kolbert. Read more: http://ow.ly/VpiGE
                            Reply
                              • Life Sciences Report | Send Message 2 Dec 2015

                                Regenerative Medicine Follows The CAR T-Cell Gravy Train: Maxim Group's Jason Kolbert... $ATHX, $BLUE, $BCLI http://seekingalpha.com/p/2qlts
                                Reply
                                  • Life Sciences Report | Send Message 18 Nov 2015

                                    " $BCLI is ideally positioned to capture interest"- Jason McCarthy. Read more: http://ow.ly/UOEka
                                    Reply
                                      • Life Sciences Report | Send Message 11 Nov 2015

                                        "The DSMB recommended $BCLI's Phase 2 ALS study continue as planned"- Jason Kolbert. Read more: http://ow.ly/UxdQv
                                        Reply
                                          Company Description
                                          Brainstorm Cell Therapeutics, Inc. operates as a biotechnology company, which develops innovative adult stem cell therapeutic products. It currently focuses on utilizing the patients own bone marrow stem cells to generate neuron-like cells that may provide an effective treatment initially for... More
                                          Sector: Healthcare
                                          Industry: Biotechnology
                                          Country: United States